147 related articles for article (PubMed ID: 29760795)
21. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies.
Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H
J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605
[TBL] [Abstract][Full Text] [Related]
22. High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance.
Wang F; Yuan S; Teng KY; Garcia-Prieto C; Luo HY; Zeng MS; Rao HL; Xia Y; Jiang WQ; Huang HQ; Xia ZJ; Sun XF; Xu RH
Eur J Cancer Prev; 2012 May; 21(3):261-7. PubMed ID: 22433629
[TBL] [Abstract][Full Text] [Related]
23. HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma.
Zhao X; Guo X; Xing L; Yue W; Yin H; He M; Wang J; Yang J; Chen J
Cell Death Dis; 2018 Jan; 9(2):61. PubMed ID: 29352124
[TBL] [Abstract][Full Text] [Related]
24. The impact of hepatitis B virus (HBV) infection on clinical outcomes of patients with diffuse large B-cell lymphoma.
Law MF; Lai HK; Chan HN; Ha CY; Ng C; Yeung YM; Yip SF
Eur J Cancer Care (Engl); 2015; 24(1):117-24. PubMed ID: 25848698
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of hepatitis B virus infection to non-Hodgkin's lymphoma].
Qin XT; Lu Y; Chen XQ; Xu HP; Fan HJ
Ai Zheng; 2007 Mar; 26(3):294-7. PubMed ID: 17355794
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of clinical characteristics and prognostic factors in patients with non-Hodgkin lymphoma and HBV infection].
Zhang L; Yuan XL; Jiang L; Yang J; Guo JM; Shi J; Lei PC; Zhang Y; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):563-568. PubMed ID: 30122015
[No Abstract] [Full Text] [Related]
27. Antiviral therapies for managing viral hepatitis in lymphoma patients.
Merli M; Rattotti S; Gotti M; Arcaini L
Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
[TBL] [Abstract][Full Text] [Related]
28. Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?
Rubio J; Franco F; Sánchez A; Cantos B; Méndez M; Calvo V; Maximiano C; Perez D; Millán I; Sánchez-Beato M; Provencio M
Leuk Lymphoma; 2015 Jun; 56(6):1686-90. PubMed ID: 25219591
[TBL] [Abstract][Full Text] [Related]
29. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
30. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
31. lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells.
Li J; Chen Y; Guo X; Bai X; Xu X; Han T; Tan A; Liu N; Xia Y; Sun Q; Guo X; Chen J; Kang J
Mol Ther Nucleic Acids; 2022 Mar; 27():1064-1077. PubMed ID: 35228900
[TBL] [Abstract][Full Text] [Related]
32. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study.
Wu J; Song Y; Su L; Xu L; Chen T; Zhao Z; Zhang M; Li W; Hu Y; Zhang X; Gao Y; Niu Z; Feng R; Wang W; Peng J; Li X; Ouyang X; Wu C; Zhang W; Zeng Y; Xiao Z; Liang Y; Zhuang Y; Wang J; Sun Z; Bai H; Cui T; Feng J
BMC Cancer; 2016 Jul; 16():537. PubMed ID: 27460571
[TBL] [Abstract][Full Text] [Related]
33. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
Huang CE; Yang YH; Chen YY; Chang JJ; Chen KJ; Lu CH; Lee KD; Chen PC; Chen CC
J Viral Hepat; 2017 Oct; 24(10):885-894. PubMed ID: 28375587
[TBL] [Abstract][Full Text] [Related]
34. PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.
Liu Z; Li S; Liu Y; Guo W; Bai O
PLoS One; 2017; 12(6):e0180390. PubMed ID: 28662185
[TBL] [Abstract][Full Text] [Related]
35. Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.
Tang Z; Li X; Wu S; Liu Y; Qiao Y; Xu D; Li J
Hepatol Int; 2017 Sep; 11(5):429-433. PubMed ID: 28856548
[TBL] [Abstract][Full Text] [Related]
36. The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.
Lu S; Xu Y; Mu Q; Cao L; Chen J; Zhu Z; Lou Y; Meng H; Qian W; Tong H; Mai W; Huang J; Yu W; Zhao X; Jin J
Leuk Lymphoma; 2015 Apr; 56(4):1027-32. PubMed ID: 25065698
[TBL] [Abstract][Full Text] [Related]
37. Detection of the Incidence of HBV, HCV Infection and Febrile Neutropenia Associated With CHOP With or Without Rituximab in Diffuse Large B-Cell Lymphoma-Treated Patients.
Ali K; Sial AA; Baig MT; Baig N; Ansari SH; Shamsi TS
Hosp Pharm; 2018 Jun; 53(3):194-197. PubMed ID: 30147140
[No Abstract] [Full Text] [Related]
38. Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma.
Makvandi K; Ranjbari N; Makvandi M; Ashraf Teimori A; Neisi N; Rasti M; Alipour V; Albokord M; Kanani M; Ahadi R; Habibian A
Jundishapur J Microbiol; 2015 Nov; 8(11):e25726. PubMed ID: 26862382
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.
Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y
J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169
[TBL] [Abstract][Full Text] [Related]
40. Clinical analysis of stages of HBV infection in 100 cases of lymphoma.
Tang Y; Sun LG; Liu CS; Li YY; Jin CH; Li D; Bai O
Asian Pac J Cancer Prev; 2013; 14(2):959-62. PubMed ID: 23621268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
